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Abstract
Precursors entering the T-cell developmental pathway traverse a progression of states
characterized by distinctive patterns of gene expression. Of particular interest are regulatory genes,
which ultimately control the dwell time of cells in each state and establish the mechanisms that
propel them forward to subsequent states. Under particular genetic and developmental
circumstances, the transitions between these states occur with different timing, and environmental
feedbacks may shift the steady-state accumulations of cells in each state. The fetal transit through
pro-T cell stages is faster than in the adult, and subject to somewhat different genetic
requirements. To explore causes of such variation, this review presents previously unpublished
data on differentiation gene activation in pro-T cells of pre-TCR deficient mutant mice, and a
quantitative comparison of the profiles of transcription factor gene expression in pro-T cell subsets
of fetal and adult wildtype mice. Against a background of consistent gene expression, several
regulatory genes show marked differences between fetal and adult expression profiles, including
those encoding two bHLH antagonist Id factors, the Ets family factor SpiB, and the Notch target
gene Deltex1. The results also reveal global differences in regulatory alterations triggered by the
first TCR-dependent selection events in fetal and adult thymopoiesis.
SEPARATE STAGES OF THE T-LINEAGE COMMITMENT PROCESS
Regulatory requirements: the basic checklist
As hematopoietic multipotent progenitors work their way towards T cell differentiation, they
shed other developmental options in a gradual process of T-lineage commitment.
Accompanying the commitment process is what can be called the “specification” process,
that is, the positive regulation of T-cell gene expression as the cells begin to adopt T-lineage
characteristics. Both the positive events that promote T-lineage gene expression and the
negative processes that block alternative fates are driven by shifting combinations of
transcription factors that propagate new gene-expression and developmental states through
successive cell cycles.
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There has been a great deal of progress in the past few years identifying the regulatory
inputs that guide T-lineage differentiation (rev. by (1;2); and see M. K. Anderson review,
this volume). In general, pro-T cell emergence depends on at least nine different kinds of
regulatory contributions, schematically shown in Fig. 1. These come from E2A and HEB
bHLH transcription factors, Runx family transcription factors, transcription factor GATA-3,
transcription factor c-Myb, Ikaros-type zinc finger family transcription factors, and TCF-1/
LEF-1 HMG box transcription factors activated by β- (or γ-) catenin. An early, hit and run
function provided by the Ets family transcription factor PU.1 is also important for
establishing the pro-T cell compartment. While most of these factors are thought to work as
activators, crucial inputs also come from dedicated repressors, including the growth-
promoting Gfi1 (Growth Factor Independence) zinc finger repressor. Finally, a crucial input
comes from Notch/Delta signaling interactions, which are mediated through RBPSuh (CSL,
RBP-Jκ) transcription factor with MAML as a cofactor (3-5).
None of these factors is a lineage-specific “master regulator”, and despite much effort, none
has yet been identified for T-cell specification. Individually, most of these inputs are shared
between the T-cell program and at least one other hematopoietic developmental program(s).
It is only in the correct combination that they specifically promote T-cell development, and
correct levels of expression are needed for their positive effects as well (2;6). Thus a critical
feature of the pro-T cell developmental program is precise regulation of expression of the
regulators themselves in precursor cells. Importantly, in the T-cell developmental process
the “correct levels” for each of these factors are not fixed, but need to undergo dynamic
alterations from one developmental stage to another (1).
Notch signaling, commitment, and pro-T cell maintenance
Of the critical T-cell regulators, the role of Notch and its mediators has drawn special
attention. This is because Notch action appears switch-like, suggesting a tight linkage
between commitment and specification. Notch signaling not only promotes the acquisition
of T cell characteristics but also blocks precursor entry into the B lymphoid lineage
pathway. Extra Notch signaling (e.g. in ectopic sites) leads to more T cell development,
while any loss of Notch signaling in the thymus can impair T-cell development and unleash
B cell development at that site (rev. by (7-9)). It has been tempting to suppose that the B-
lineage inhibiting features of Notch signaling are equivalent to its T-lineage promoting
features, and that B-lineage inhibition by Notch is equivalent to T-lineage commitment.
However, this is not the way most precursors appear to become committed in vivo. B
lineage inhibition is not the conclusion of T-lineage commitment, and it is not the last role
that Notch signaling needs to serve in pro-T cell development.
A multitude of studies have now shown, both in fetal and in adult thymocytes, that B-cell
potential is lost before or immediately after precursors arrive in the thymus, whereas
individual intrathymic precursors remain capable of giving rise to natural killer (NK) cells,
dendritic cells (DC), and/or even macrophages as well as T cells (10-22). Meanwhile, Notch
signaling from the thymic microenvironment is needed for additional, continuing roles in
pro-T cell development and viability extending long after B-lineage potential is suppressed
(14;23;24). This lineage-specific survival role extends right up to the point when the first
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productive rearrangement of the T-cell receptor (TCR) genes has occurred. We can therefore
define at least three different stages in the pro-T cell commitment process: loss of B-lineage
potential, Notch-dependent expansion while DC and NK potential is preserved, and loss of
DC and NK potential. The temporal split between the loss of B cell potential and the loss of
other alternative potentials confirms that different mechanisms must regulate different
components of the commitment process, as previously suggested (25), and gives a lower
bound to the duration of the process as a whole. T-lineage commitment may actually begin
even earlier, with a separate loss of erythro-megakaryocytic potential before the loss of B-
cell potential (22;26-28). If so, the full process must be even more protracted and
mechanistically segmented.
T-cell development is therefore a composite of distinct regulatory subroutines. One
subroutine presumably represses the B-cell fate, others repress the NK fate and the DC fate,
and others cause onset of pro-T cell gene expression. Meanwhile, the proliferation and
checkpoint arrest timing that accompanies these events may be regulated by yet other
regulatory subcircuits. Because these subroutines are not active simultaneously, they need to
be accounted for by time-dependent changes in regulatory factor activities.
Stages and success criteria for pro-T cell differentiation
The various phases of pro-T cell differentiation within the thymus can be mapped against
the changing surface expression patterns of CD44, CD25, HSA (CD24), and c-kit on cells
that have not yet expressed TCR complexes or the coreceptors CD4 or CD8. These define
the DN1-DN4 stages (18;20;29)(see legend to Fig. 2). Fig. 2 summarizes the stages at which
major changes in developmental potential occur. Changes from the DN1 stage through the
DN3 stage are all T-cell receptor independent, and these encompass the pro-T cell stages.
Throughout the DN1 and DN2 stages, commitment is still incomplete. These cells can still
give rise to natural killer cells, dendritic cells, or even macrophages, if moved to a new
signaling microenvironment (10;19;24;30-33). Commitment is only complete by the DN3
stage. Subsequently, transit from the DN3 stage to a DN4 stage then depends strictly on
TCR-dependent selection, either β-selection or γδ-selection, and marks the end of pro-T cell
development.
The pro-T cell stages of development, which precede TCR expression, could be considered
peripheral to the immunological functions of T cells, but they are important to accomplish
several “goals”. One is extensive proliferation, amplifying a small number of precursors to a
very large number of cells auditioning for selection (34). Another goal is to lead a precursor
from multipotentiality to T-lineage commitment. A third goal is to arm the cell with the
signaling apparatus that will enable it to detect successful TCR gene rearrangement. Fourth,
of course, is the assembly of at least one good TCR coding sequence by RAG-mediated
recombination of the TCRβ locus or the TCRγ and δ loci. The fifth goal is to transform the
survival requirements of these hematopoietic cells to make them completely dependent on
TCR expression, either a pre-TCR (pTα + TCRβ) or a γδ TCR. Thus, this fifth goal of the
pro-T cell stage effectively sets a deadline for TCR gene rearrangement and enforces it with
a death penalty. Of course this last “goal” must be delayed with respect to proliferation.
Indeed, the interval from precursor entry to β-selection has been estimated as about two
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weeks in the adult thymus, encompassing at least 10-12 rounds of cell proliferation (and
probably more), and with at least 7-10 rounds of division in the fetal thymus (34-36).
Correct timing of the regulatory change concluding lineage commitment may be critical for
generation of an adequate number of T-cell precursors. This is particularly the case in the
adult thymus, where after the proliferative burst at β-selection, further selection and
differentiation are carried out essentially without additional cell division (37;38).
HOW MUCH PLASTICITY IS INTRINSIC TO PRO-T CELL DEVELOPMENT?
Fast or slow timing of state transitions
Diagrams like Fig. 2 imply that T-cell development is a kind of pipeline through which the
cells inexorably move forward in a fixed timecourse. However, several systems provide
evidence that the flow of cells through the pro-T cell stages can be subject to regulatory
variations.
Passage from DN1 precursor stage to DN2 and DN3 stages may be regulated by homeostatic
feedbacks in some cases. In Rag-knockout animals and other mutants that cannot assemble a
pre-TCR, there is no successful differentiation beyond the DN3 stage, and this appears to
alter the passage through the stages leading up to the DN3 stage. The DN2 compartment is
generally much reduced and canonical c-kithi DN1 cells are scarce or absent (39-41). Thus,
precursors may not be allowed to enter the thymus (40), or their development may be
arrested immediately within the thymus with downregulation of c-kit, or both.
Additional evidence for flexibility within the pro-T period has emerged recently through the
use of the new OP9-DL1 stromal coculture system, which supports T-cell development with
a combination of Notch ligand and cytokine-mediated signals (42;43). While the cells
progress to β-selection and generate DP cells nicely in this system, there is often a distortion
of the distribution of cells among subsets as they pass from the DN1 to the DN3 stage,
suggesting that the DN2 compartment is substantially expanded under these conditions (e.g.,
(44)). Environmental factors such as IL-7 concentrations as well as differences in precursor
sources (adult vs. fetal) can influence the differentiative “pausing” in vitro (45)(T. Taghon &
EVR, unpublished data). This is most interesting because in this situation the proliferation
continues, decoupled from differentiation to some extent. More work is needed to determine
exactly how well the gene expression in these cultured DN2 cells matches that of DN2 cells
in vivo, or exactly how many additional cell cycles, if any, they can undergo before moving
on to the DN3 state; the evidence is still mostly suggestive. Nevertheless, the pattern seen in
the OP9-DL1 system is a hint that the DN2 state can be maintained through more cell
divisions than it normally occupies in the thymus, where the cells are forced to migrate
between domains with differing levels of IL-7 and Notch ligand presentation (36;46).
Conceivably the regulatory cascade within DN2 cells does not necessarily cause them to
“fall forward” to the DN3 state unless environmental conditions help to “push” them there.
Possibilities of detours or shortcuts in thymocyte development
Most surprisingly, recent evidence has suggested that individual cells can make their ways
through the pro-T cell stages by noncanonical routes that appear to miss some normal stages
altogether. None of these cases are fully analyzed yet, but they suggest that under some
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circumstances the dwell time in the DN2 and/or DN3 stages can be greatly reduced. One
case is the phenotype of DN thymocytes in a newly described mutant which has abnormal
thymic epithelium as a result of a splicing mutation in the Foxn1 gene (47). After birth, the
thymus in these mice becomes generally hypocellular, but relative to other subsets the DN3
thymocyte subset appears to be most severely depleted, even under conditions where DP
cells are still readily detectable. The suggestion is that defects in the microenvironment force
those DP cells that do emerge to take a route that shortcuts past the DN3 stage. A second,
striking case is that of the development of certain uncommitted precursors in the thymus that
do not fit neatly into the standard DN1-DN2-DN3 classification. While the most potent early
T-lineage precursors are the c-kit+ subset(s) of CD25- CD44+ cells (18;29;48), for which we
have reserved the term “DN1”in this review, there are also certain c-kitlow HSA+ subsets of
CD25- CD44+ cells that contain other kinds of precursors showing some T-lineage potential.
These can give rise to DP cells, with reduced efficiency, but they do so without apparently
generating any detectable DN2/3-like intermediates at earlier timepoints (18). A third, final
case of a possible detour is the effect observed in murine or human T-cell development
when the transcription factor GATA-3 is overexpressed by retroviral transduction. Once
again, there are hints that a modest number of cells can succeed in reaching the DN4 and/or
DP state, but with a notable depletion of any DN3-stage intermediates or their equivalent in
human thymocytes (49;50)(T. Taghon and E. V. R., unpublished data). This suggests that
the cells may skip to β-selection directly from the DN1 or DN2 stage.
Taken together, these cases raise the possibility that T-cell development could be less like a
pipeline and more like the path of a river through a valley, with varying degrees of
“eddying” and “meandering” in the normal case which can be expanded or bypassed in
abnormal conditions (Fig. 3). Variability in such paths can be understood in terms of a
varying balance among the “self-renewal” and “progression” functions at each pro-T cell
stage that respectively amplify and cause exit of cells from that stage. However, the question
remains: how much of this potential variation is used physiologically? One natural
comparison is between the pro-T cell differentiation process in adult and fetal thymus.
Behavioral and lineage-choice differences among fetal, postnatal, and adult T-cell
development
There are a number of striking differences between fetal and adult hematopoiesis and
lymphoid development. First and foremost of these is the difference in time required for
fetal mouse thymocyte maturation as compared to postnatal mouse thymocyte maturation. In
the fetus, the first lymphoblastic immigrants to the thymus arrive at E13.5 or so and the first
DP thymocytes emerge by E16.5, a total span of 3 days. In the postnatal thymus, the
immigrants are estimated to take at least ten days to reach the DN3 stage, and about two
weeks to differentiate into DP cells (35). This suggests a difference of at least fourfold in the
overall length of time spent traversing the pro-T cell stages. In part, the difference in transit
time may be due to distinct properties of the hematopoietic stem cells that are made at
different stages of ontogeny (rev. by (51;52)). The earliest intraembryonic stem cells (from
the aortic-gonadal-mesonephric region), fetal liver stem cells, and adult bone marrow stem
cells are all subtly different in their self-renewal potentials and genetic requirements, and all
markedly different from the first hematopoietic precursors in the extraembryonic yolk sacs.
David-Fung et al. Page 5
Immunol Rev. Author manuscript; available in PMC 2014 September 08.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Accordingly, the timing, cell fate assignments, and genetic requirements of early murine T-
cell development from these precursors are somewhat different in three different stages of
life: fetal, young postnatal (up to 3-4 weeks), and adult.
The fetal thymus is unique for harboring at least one developmental pathway that is not
supported in the postnatal thymus at all. The first cells to seed the fetal thymus, around
E12.5-13.5, are also the one group of precursors that can generate specialized lineages of
TCRγδ cells that have largely invariant receptors (53;54)(rev. by (55-57)). These γδ cells are
the first TCR+ cells to be produced by the fetal thymus (around E15.5). They have
distinctive homing properties, as they are targeted to epithelia for their function, and they
have distinctive cytokine receptor usage even before leaving the thymus, as they depend on
IL-2/IL-15Rβ (CD122) for proliferation as well as on IL-7R signaling for inducing their
TCRγ gene recombination (58;59) (60). The production of these γδ cells appears to depend
on unique properties both of the hematopoietic precursors in the first wave of fetal
thymocyte development and of the fetal thymic microenvironment (54). It is notable that the
rearrangement events that generate the specific fetal types of TCRγ and TCRδ chains are
facilitated by lower levels of activity of the bHLH protein E2A, and disfavored by higher
levels (61). Complementary to the fetal γδ T-cell lineages, there is another important T-cell
lineage, the CD1-restricted invariant NKT cells, that is produced only by the postnatal
thymus, and not in the fetus (62;63).
Several aspects of the ordering of developmental lineage choice appear to be different
between fetal and adult precursors. Prethymically, a major difference is that all fetal
precursors that still retain B as well as T potential also retain myeloid potential
(22;27;64;65); truly lymphoid-restricted “common lymphoid progenitors” are reported only
after birth (66;67). Within the fetal thymus, a major population of DN1 precursors shows
T/NK potential, and a wave of NK cells matures in the thymus before any T-cell maturation
(32;60;68-70). NK cells are dramatically expanded in fetal thymic organ culture when IL-2
is added (60). This is much more prominent than NK development in the normal adult
thymus.
Different genetic requirements among fetal, postnatal, and adult pro-T cells
Fetal thymocytes differ from postnatal thymocytes in their dependence on two transcription
factors, the Hunchback-type zinc finger transcription factor Ikaros (Znfn1a1) and the Ets-
family transcription factor PU.1 (Sfpi1, Spi-1). Mutants with null Ikaros function have no
fetal thymopoiesis, but immediately after birth a fairly normal wave of T cell development
begins and eventually generates a substantially well-populated thymus (71). It has been
more difficult to study the role of PU.1 in fetal vs. adult thymocytes because true null
mutants of PU.1 do not permit survival beyond birth (72-74), at least in part because of a
complete lack of macrophages as well as acute hematopoietic progenitor defects. However,
a severely hypomorphic PU.1 mutant exists that allows mice to survive for a week or two
after birth if kept on antibiotics (75). This mutation, also, completely blocks fetal thymocyte
development, but after birth, T cell development begins in the thymus and continues as long
as the animals can be kept alive, even while macrophage and B-cell development remains
absent (75). Neither the Ikaros case nor the PU.1 case should be interpreted to mean that
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postnatal T-cell development is really “independent” of the factor’s activity. In Ikaros-null
mutants, the ability of postnatal T-cell development to proceed is almost certainly due to the
compensatory activity of closely related Ikaros-family transcription factors, such as Helios
and/or Aiolos, because in mice transgenic for a dominant-negative allele of Ikaros there is
no T-cell development at all (71;76). In the case of PU.1, most recently, conditional
knockout alleles have been made that enable the PU.1 gene to be disrupted in adult bone
marrow. These studies show that even in the adult, a complete deletion of PU.1 eliminates
the ability of the bone marrow to contribute to T-cell development in an adoptive transfer
host (74;77). Thus the emergence of some T cells in the postnatal hypomorphic PU.1 mutant
may reflect some residual activity and the absence of competition in the mutant
environment. Still, the striking difference in impact of these mutations on the thymus before
and after birth implies that the fetal and postnatal T-cell development programs use these
factors in quantitatively or qualitatively different ways.
Fetal and postnatal T-cell development differ in the ways they use IL-7 receptors for
survival and population expansion. IL-7R signaling works through activation of PI3K and
STAT5 for proliferative, antiapoptotic, and differentiative effects (78). Postnatal T-cell
development is acutely dependent on canonical IL-7 receptors, i.e. heterodimers of IL-7Rα
(CD127) and γc (CD132). Mutants lacking either chain are severely disabled in postnatal T-
cell development, specifically through the pro-T cell stages (40;79-89). This pro-T cell-
specific role of IL-7R signaling is partly based on its ability to maintain anti-apoptotic Bcl-2
levels, but Bcl-2 transgene expression is not sufficient to replace all roles of IL-7R signaling
in pro-T cell proliferation (82;85;90). IL-7R signaling has another role as well, a very
specific requirement to activate STAT5, which is needed to open the TCRγ loci for
recombination and make γδ T-cell development possible (91-98). Beyond the DN3 stage,
IL-7 receptor signaling must be downregulated to allow adult pro-T cells to generate DP
cells (99). Thus, any IL-7R-deficient mutant cells that do manage to reach the β-selection
checkpoint can then undergo efficient proliferation and differentiation to the DP stage and
beyond.
In view of these diverse roles in postnatal T-cell development, it is remarkable that fetal T-
cell development appears to begin almost normally in IL-7R mutants. Fetal TCRγδ
rearrangement is blocked in the mutants, but proliferation apparently is not. Thus the first
wave of fetal precursors appears to traverse the DN1-DN3 stages comparably in wildtype
animals and in at least one IL-7R mutant strain (100). This is not because fetal thymocytes
are cytokine-independent: fetal thymocyte generation is reported to be more, not less,
dependent on STAT5 than postnatal thymocyte development (98). However, there appears
to be a general division of labor between the IL-7R and IL-2/IL-15R complexes for
maintaining survival of fetal-lineage cells (59;60;101). Analysis of IL-7-deficient mutants
shows that of the surviving γδ T cells, fetally derived γδ cells which populate the skin are
less dependent on environmental IL-7 for their maintenance in the periphery than adult-
generated γδ cells (102). To the extent that the IL-2/IL-15R complex transduces slightly
different signals than the IL-7R complex, with tighter coupling to Grb2/Ras pathways
(103-105), fetal thymocytes (and especially fetal-lineage γδ cells) may also develop in a
somewhat different activation state than adult thymocytes. Accompanying their reduced
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dependence on IL-7R signaling, fetal pro-T cells are also less sensitive than adult pro-T cells
to inhibition of DP generation by IL-7R signaling at β-selection (45).
A three-way split between the fetal, immediate postnatal, and fully adult thymocyte
developmental requirements is revealed through the functions of the Wnt/ β-catenin/ TCF
pathway, with a reversal of the pattern seen for PU.1 and Ikaros mutants. The TCF-1
transcription factor (encoded by the Tcf7 gene) is expressed very highly in thymocytes (see
Fig. 4). When mutated, there is little effect on fetal thymocyte development, but postnatal
development is strongly impaired at β-selection (DN4 to DP), and as the animals age beyond
a month old, an increasingly severe defect is seen in the transit of pro-T cells from the DN1
to the DN2 stage (106;107). The relatively mild effect in fetal development is due to the
masking of TCF-1 deficiency by the activity of the closely related LEF-1 gene. Thus, in
double mutant fetal thymocytes a strong block is revealed very similar to the block in single
TCF-1 mutant postnatal thymocytes (108). The double mutant phenotypes show that TCF-1
and LEF-1 are needed specifically for TCRα expression, for αβ-lineage T cell development
immediately after β-selection, and for replenishment of the DN1/2 precursor compartments
in fetal thymocytes. The same general functions can be ascribed to TCF-1 in postnatal T-cell
development (109-111), so the difference is that after birth LEF-1 does not seem to be able
to compensate for TCF-1 deficiency.
To summarize, even though both the adult and fetal thymus produce recognizable T cells,
they do so by somewhat different pathways that depend on different viability and
proliferation functions and may also permit access to different lineage alternatives. Thus,
while certain aspects of T-lineage specification are fundamentally constant, they are
embedded in processes with significant regulatory flexibility.
MAJOR MOLECULAR BENCHMARKS FOR PRO-T CELL DEVELOPMENTAL
PROGRESSION
Differentiation gene expression patterns and regulatory gene expression patterns
The most obvious activity that the regulators of T-cell development must carry out is to turn
on the “differentiation genes” that confer critical functional properties on the differentiating
hematopoietic cells. By this criterion, the T-cell program is under way by the DN2 stage:
this is what is meant by “specification” in Fig. 2. For example, Fig. 4A shows quantitative
real-time PCR analysis of the expression of the differentiation gene CD3ε in DN1-4
thymocyte subsets, and patterns similar to that of CD3ε here have also been reported for
pTα (112;113). Additional data for Rag1 are shown in Fig. 5 and reported elsewhere (114)
(T. Taghon, M. A. Yui, R. Pant, R. A. Diamond, and E. V. Rothenberg, manuscript
submitted). All of these genes are activated detectably by the DN2 stage with a strong
increase between DN2 and DN3. Presumably at least some of the temporal control of genes
like CD3ε, pTα, and the Rag genes reflects their requirements for the T-lineage transcription
factors that are also specifically upregulated during the specification process. The T-lineage-
specific transcription factors GATA-3 and TCF-1 and the critical T-lineage bHLH family
member HEB also increase in expression from DN1 to DN3 (Fig. 4A). However, transcripts
of these regulatory genes increase in expression much more gradually than the CD3ε gene.
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While the general upward trends are timed similarly, there is a striking difference in slope.
At the same time, the early-acting factor PU.1 drops in expression by up to four orders of
magnitude between the DN1 and DN3 stages.
The difference in steepness of induction between T-lineage differentiation genes and T-
lineage regulatory genes raises the question of exactly how the transcription factor activity
brings about specification, and two non-exclusive possibilities can be suggested (Fig. 4B,
C). One is that the regulation of targets like CD3ε depends on combinatorial action of
multiple T-lineage transcription factors, such that the differences in the factor concentrations
act multiplicatively (Fig. 4B). Another is that GATA-3, TCF-1, and HEB are not the right
transcription factors to be looking at in this comparison, and that some other regulatory
input, which itself increases more steeply, is the one that truly accounts for the magnitude of
differentiation gene induction (Fig. 4C). Data shown below will suggest a limited number of
candidates for factors that could provide qualitatively specific positive functions with a
sharper slope of developmental increase. However, such candidates are a small minority. We
have made a systematic attempt to identify most of the transcription factors that are actively
expressed during the pro-T cell stage (E.-S. David, G. Buzi, L. Rowen, R. A. Diamond, M.
K. Anderson, and E. V. R., in preparation; C. C. Tydell, E.-S. David, L. Rowen, and E. V.
R., unpublished data), in a gene discovery project based on an arrayed cDNA library from
SCID thymus pro-T cells (115). It is striking that the great majority of the “new”
transcription factor genes identified in this screen show less upregulation during the pro-T
cell stages than GATA-3, TCF-1, and HEB, not more (E.-S. David, G. Buzi, L. Rowen, R.
A. Diamond, M. K. Anderson, and E. V. R., in preparation; E.-S. David, C. C. Tydell, and E.
V. R., unpublished data). At the same time, some of the most dramatic transitions in
transcription factor expression from the DN1 to the DN3 stage are exemplified by the
downregulation of factors like PU.1 (see Fig. 4A). Thus it seems most likely that the timing
of differentiation gene activation is based not on a single “master regulator” that defines the
T-lineage specification clock, but rather on the combinatorial interactions of positive
regulators (Fig. 4B). Such combinatorial models could be extended to include
developmentally-controlled de-repression by rapidly dropping levels of potential
antagonists.
T-lineage gene expression begins in precommitment stages
Activation of the T-lineage gene expression program can be induced coordinately in vitro
(116;117). However, in the adult thymus in vivo, there is evidence that individual T-lineage
differentiation genes are expressed in varying combinations long before T-lineage
commitment, and to some extent, in additional intrathymic cells that may have little or no T-
lineage precursor activity. This noncoordinate regulation of T-lineage genes can be seen in
Fig. 5, where several unconventional populations of immature lymphocytes in the thymus
are examined functionally and phenotypically.
It has been evident for a long time that there are DN cells in the thymus that are not on the
direct DN1-DN2-DN3 pro-T cell path as defined by markers c-kit, CD44, and CD25. Many
of these obscure cells are CD44+ CD25- but not c-kit+. After ruling out contaminating TCR+
mature cells, B-lineage cells, and mature cells of other hematopoietic types, there remain
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several classes of thymocytes that appear to be immature lymphoid or multilineage
precursors, as shown in Fig. 5 and as defined elsewhere by other combinations of markers
(18;48;118)(see legend to Fig. 5 for details and additional references). The surprising fact is
that substantial numbers of T-lineage genes appear to be activated even in some of these
subsets that do not include canonical DN1 cells (18)(Fig. 5D, E: lanes 4, 5).
The c-kit+ DN1 cells themselves constitute a subset within the Sca-1+ Thy-1lo CD4- HSAlo
population of CD44+ CD25- cells (Fig. 5A). Accordingly, the Sca-1+ Thy-1lo HSAlo subset
(population 3, Fig. 5B) is also enriched for T-lineage progenitor activity (Fig. 5C). The
Sca-1- HSAlo subsets (Thy-1+ and Thy-1-, populations 1 & 2) are almost uniformly positive
for NK cell surface markers (119;120) and express NK-associated genes like perforin (Fig.
5D, E, lanes 1, 2). These NK-like cells, as expected, do not differentiate into DN2 or DN3
cells in fetal thymic organ culture (Fig. 5C). However, there are also two other populations
(Fig. 5B: populations 4 & 5) which show substantial expression of particular T-lineage
genes in vivo, including CD3ε as well as TdT and germline transcripts of Vβ8.2 (Fig. 5D, E,
lanes 4 & 5) even though cells in these populations cannot develop into DN2 or DN3 cells
(Fig. 5C, pop.5 = Sca+ Thy+; for pop. 4, see(121;122)). CD3ε, in spite of its dramatic
upregulation within the canonical pro-T cell pathway, is clearly upregulated in non-
canonical immature cells as well (Fig. 5D & E, lane 5)(18). Whether these cells are
“decommissioned” T-cell precursors or cells of alternative lineages expressing T-cell genes
in a “cross-lineage” fashion is not resolved, but clearly some T-cell differentiation genes are
accessible to cells that are not committed to a T-cell developmental fate. In fact, sensitive
transgenic and knock-in approaches have recently shown that the cis-regulatory sequences
of pTα and Rag-1 become activated in multilineage lymphoid precursors even before entry
into the thymus (67;112;123), even though these genes are expressed much more strongly
afterwards, in the DN3 stage. These results emphasize that T-lineage differentiation gene
expression is not uniquely coupled to commitment.
T-lineage gene expression is fully under way by the DN2 stage at the latest, with RAG
genes, germline TCR Vβ segments, pTα, CD3ε, Lck, and TdT (in adult mice) already being
transcribed (119;124;125)(Fig. 5D & E, lane 6=DN2 cells, lane 7=DN3 cells). Virtually all
T-cell differentiation gene transcripts expressed by DN3 cells are already detectable in DN2
cells, although some are upregulated substantially between these two stages (e.g. pTα and
Rag-1). Negative as well as positive regulation may reinforce the T-lineage identity of these
cells, because the “non-T” genes expressed in other immature thymocyte subsets (Fig. 5, D,
E: genes marked with asterisks) are largely or completely repressed in the DN2 as well as
DN3 cells (Fig. 5D, E, lanes 6. 7).
Commitment and checkpoint imposition in the DN3 stage
Proliferation is greatest during the the DN1 and DN2 stages, and then pauses at the DN3
stage, while TCR gene rearrangement becomes maximal at the DN3 stage. Successful TCR
gene rearrangement is detected by preTCR assembly, and therefore the components of the
pre-TCR signaling complex must be in place by the time cells reach the DN3 stage.
Accordingly, the CD3 components, signaling kinases, and the surrogate TCR chain pTα
reach a peak of expression in the DN3 stage, along with expression of the Rag genes
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(10;112;126)(T. Taghon, M. A. Yui, R. Pant, R. A. Diamond, and E. V. R., ms. submitted).
On the other hand, cytokine-mediated proliferation, which has continued through the DN1
and DN2 stages, is brought to a halt in the DN3 stage (127). This coincides with the
downregulation of c-kit, the growth factor receptor that apparently sustains proliferation of
precursors immediately before entry and in the earliest stages within the thymus
(86;128;129). The main cytokine receptor driving intrathymic DN2 proliferation, the IL7R,
continues to be expressed at the DN3 stage, but can no longer drive proliferation (114;130).
This arrest in the DN3 stage is the checkpoint from which cells can only emerge by
successful TCR rearrangement. Disabling of the cytokine-mediated proliferation apparatus
appears to be important to enable the TCR-dependent phases of αβ T cell development to
proceed normally (45;99;131;132).
Cell transfer experiments indicate that the DN3 cells are the first to be fully committed to
the T-cell lineage (19;24;30;133;134). Commitment, therefore, is associated with
proliferative arrest and with the imposition of a new requirement for pre-TCR expression
before proliferation can resume. We have argued that this committed state is a result of the
sharp downregulation of “non-T” regulatory genes like PU.1 in this stage (135). PU.1
expression is required for the cells to maintain DC potential and induces DC marker
expression on fetal thymocytes (136). If PU.1 expression is added back to purified DN3
cells by retroviral transduction, the cells can transdifferentiate to a myeloid-like phenotype
(137).
Even once committed, pro-T cells remain acutely dependent on Notch signaling for viability
(138), in a role apparently distinct from the previous effects of Notch on lineage choice
(24;116;139). Notch1 and Notch3 expression and activation of Notch target genes are
maximal at the DN3 stage. In fact, these levels are significantly higher than in the DN1
stages when B-cell potential is presumably just being suppressed (14;140;141)(T. Taghon,
M. A. Yui, R. Pant, R. A. Diamond, and E. V. R., ms. submitted). The shift from cytokine-
dependent proliferation to Notch-dependent survival, pending pre-TCR-dependent rescue,
thus imposes a distinctive gene expression signature on the DN3 cells.
Rite of passage: regulatory transitions at β-selection and exit from the pro-T cell state
The pro-T cell stages end abruptly, either with (pre)TCR-dependent selection (β-selection or
γδ-selection) or with death. β-selection triggers the second major phase of proliferation in
thymocyte development, normally producing an approximate hundred-fold increase in cell
numbers as the cells make the transition to the CD4+ CD8+ (DP) stage. This proliferation
dilutes out gene products that were expressed in the pro-T cell stages and helps clear the
decks for the new physiological state, installed in the DP cells, that makes TCR-dependent
positive and negative selection possible. The extent of proliferation, however, can be
regulated separately from the simple triggering of β-selection or γδ-selection per se. This is a
major point where effects such as those diagrammed in Fig. 3 can be manifested.
Perturbations that reduce proliferation generally have a disproportionate effect on steady-
state levels of DP thymocytes, whether or not they interfere with β-selection as a
differentiation program. Furthermore, cells choosing the γδ T-cell fate as an alternative to β-
selection can mature with much less proliferative expansion, as we have recently been able
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to measure directly (T. Taghon, M. A. Yui, R. Pant, R. A. Diamond, and E. V. R., ms.
submitted). As a result, perturbations that block proliferation can alter the effective αβ:γδ
thymocyte ratio without necessarily affecting the αβ/γδ lineage choice itself.
Much excellent work has focused on the way β-selection triggers proliferation, changes in
TCR gene accessibility for recombination, and allelic exclusion (rev. by (142-147)).
However, in addition to these effects, it profoundly transforms the physiology of the cells,
swapping apoptosis control functions, blocking transcriptional responses to some activation
pathways, enhancing responses to others, and temporarily installing a distinctive set of
functions unlike those of mature T cells (rev. by (148)). Detailed comparisons of young
adult thymocytes before and after β-selection show that these effects are accompanied by
diverse regulatory changes, including both transient responses to the β-selection signal
(149-151) and longer-term alterations that play an active role in the unique physiology of
DP cells, the major population of thymocytes that is generated by β-selection
(99;130;152-156). The IL7R signaling capability is further disabled, and IL7Rα mRNA
expression is shut off (114;130). Certain transcription factors, including Ets-family factors
SpiB and Erg, and an alternative promoter-use variant of the bHLH factor HEB, are sharply
downregulated at β-selection and apparently never used in T-cell development again
(114;115;157)(D. Wang, et al., ms. submitted).
Another critical change that occurs at β-selection is that thymocytes are weaned from their
dependence on Notch/Delta signaling for the first time since their entry into the T-lineage
pathway (45;140;158;159)(T. Taghon, M. A. Yui, R. Pant, R. A. Diamond, and E. V. R., ms.
submitted). Among the genes that are precipitously downregulated in the process are
Notch1, Notch3, HES-1, and other Notch target genes (14;45;114;140;141;160;161)(T.
Taghon, M. A. Yui, R. Pant, R. A. Diamond, and E. V. R., ms. submitted). The end of the
pro-T cell stage is therefore the point at which thymocytes exchange their dependence on
Notch for a new dependence on TCR signals for subsequent developmental decisions and
survival.
A DIRECT COMPARISON OF FETAL AND ADULT PRO-T CELL GENE
EXPRESSION PROGRAMS
Comparison between pro-T cell gene expression patterns in fetal and postnatal
thymocytes
The landmark stages in adult pro-T cell development just reviewed include many distinct
regulatory functions in which differences might be found between adult and fetal programs.
For the remainder of this review, we discuss evidence identifying discrete gene regulatory
changes that may contribute to these differences. Adult and fetal pro-T cell development, as
we have noted, differ both in the speed of differentiation relative to proliferation and in the
details of the kinds of T cells produced. This suggests that a direct comparison of adult vs.
fetal pro-T cell gene expression is likely to show commonality for those genes that control
all the core features of the pro-T-cell developmental program, while showing differences in
genes that control either the population dynamics or the generation of specific fetal γδ T
cells as opposed to αβ T cells. We have therefore undertaken a systematic comparison of the
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expression patterns of a series of transcription factors and differentiation genes in purified
pro-T cell subsets of E14.5 fetal mice and young adult mice (M. Morales, E.-S. David, M.
A. Yui, and E. V. R.; Figs. 6-9 and data not shown).
DN1, DN2, DN3 and DN4 subsets were therefore purified from fetal thymocytes or from
Lin-depleted adult thymocytes (114) by a modification of the method of Ceredig and Rolink
(29)(E.-S. David, G. Buzi, L. Rowen, R. A. Diamond, M. K. Anderson, and E. V. R., in
preparation). Details are described in the legend to Fig. 6. This method includes rigorous
selection for c-kit+ progenitor-type cells to define the DN1 and DN2 populations. DN4 cells,
produced by β-selection or γδ-selection, were purified as the HSA (CD24)+ CD25- CD44- c-
kit- fraction while DN3 cells in total were purified as the HSA+ CD25+ CD44- c-kit-
fraction. To obtain further insight into immediate consequences of β-selection signaling,
some preparations of DN3 cells were further subdivided into DN3a and DN3b populations,
using a new method we have described elsewhere (T. Taghon, M. A. Yui, R. Pant, R. A.
Diamond, and E. V. R., ms. submitted for publication) to separate DN3 cells that have not
yet received β-selection or γδ-selection signals (DN3a) from those that have (DN3b). cDNA
samples from these fractions were then probed for expression of regulatory genes by
quantitative real-time PCR, using the primer pairs listed in Table 1. All fetal/adult
comparisons were made for each primer pair by running two independent series each of fetal
and adult samples together in the same analysis. β-actin measurements from the same
sample dilutions were used to normalize the results, as previously described (114). All the
data shown are measurements of gene expression in the same four series of cDNA
preparations, and they therefore serve as controls for the specificity of changes in each
other’s expression. Moreover, the gene expression patterns illustrated here are all supported
by additional independent analyses of separate adult and/or fetal samples (114)(T. Taghon,
M. A. Yui, R. Pant, R. A. Diamond, and E. V. R., ms. submitted for publication)(E.-S.
David, G. Buzi, L. Rowen, R. A. Diamond, M. K. Anderson, and E. V. R., in preparation).
Detailed methods for the gene expression measurements are to be presented elsewhere (E.-S.
David, G. Buzi, L. Rowen, R. A. Diamond, M. K. Anderson, and E. V. R., in preparation).
The results (Figs. 6-9) show overall consistency between the fetal and adult pro-T cell gene
expression patterns, but with a few remarkable differences. The genes analyzed fall into
three general classes in terms of the fetal/adult comparison. “Class 1” genes are expressed
indistinguishably between corresponding adult and fetal samples; any variation falls within
the range of error of separate preparations of pro-T cells from the same stage of life. “Class
2” genes are expressed in parallel ways in fetal and adult thymocytes throughout the DN1
and DN2 stages, but then show widening differences between fetal and adult samples at the
DN3 and DN4 stages. Many of these are genes that are downregulated in adult thymocytes
during β-selection: these tend to continue to be expressed at pre-β-selection levels in all fetal
DN3 and DN4 cells. “Class 3” genes are genes that are expressed at greatly different levels
in fetal and adult pro-T cells throughout all the pro-T cell stages. These “class 3” genes are
generally expressed at least tenfold more strongly in fetal thymocytes than in adult
thymocytes, as compared to β-actin. Many of these “class 3” genes also show the more
persistent pattern of expression in fetal DN3 and DN4 thymocytes that is characteristic of
the “class 2” genes. To interpret these expression patterns in terms of transcription factor
function, the results are discussed in groups according to gene family.
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bHLH family transcription factors: selective modulation of Id1 and Id2
E2A and HEB bHLH transcription factors are important positive drivers of T-cell gene
expression, both as homodimers and as heterodimers (rev. by (162;163)). They are
expressed at the RNA level throughout the pro-T cell stages at high, comparable, but
relatively unchanging levels. There is a gentle rise in HEB from the DN1 to the DN3 stage
and a flatter pattern of E2A RNA expression in these stages as shown in Fig. 6A and B (also
see Fig. 4A). As is often the case in these analyses, quantitative PCR of the independently
prepared sample series from adult (pink and navy) and fetal (yellow and cyan) pro-T cells
gives some inter-series scatter. However, the results for the fetal samples lie within the range
of variation between the adult samples. These genes are therefore “class 1” in terms of fetal/
adult similarity. The activity of bHLH factors in vivo, however, depends on the levels of
their antagonists, including the HLH Inhibitors of DNA Binding Id1, Id2, and Id3. Id3 plays
an important role in proliferative expansion at β-selection as well as in activating the later
maturation events of positive selection, whereas Id2 promotes proliferation in a number of
contexts and is a critical regulator of NK cell development (163-165). For these reasons, and
in view of the high level of NK potential of fetal pro-T cells, the Id factor expression
patterns are of great interest. In the adult thymus, only Id2 and Id3 are significantly
expressed, but the Id factors show a different pattern in the fetal thymus. Like E2A and
HEB, Id3 is expressed very similarly in the adult and fetal thymocytes. In both adult and
fetal samples, Id3 is insignificantly expressed in the DN1 and DN2 stages but upregulated in
the DN3 stage, especially the post-selection DN3b cells, and sustained in DN4 cells (Fig.
6C). However, Id1 and Id2 are expressed in dramatically different ways, defining “class 3”
relationships between fetal and adult. Id1, which is expressed at extremely low and
irreproducible levels in adult pro-T cells, is expressed throughout the fetal pro-T cell stages
at 10-100 fold higher levels (Fig. 6D). Id2, on the other hand, is expressed in the DN1-3
stages but downregulated at β-selection in adult cells, yet it begins expression at a higher
level in fetal DN1 and DN2 cells and then sustains equal or increasing expression through
the DN3 and DN4 stages (Fig. 6E). By the DN3b and DN4 stages, normalized Id2 levels are
20-50 fold higher in the fetal pro-T cells than in the adult pro-T cells.
Thus in spite of consistent bHLH expression, there is a substantially higher level of potential
bHLH antagonism in fetal pro-T cells, starting with the high level of Id1 in all fetal pro-T
subsets and including an elevated and sustained expression of Id2. The difference in overall
bHLH activity predicted from these expression patterns could account both for the high
efficiency of NK cell development from fetal pro-T cells (69) and for the highly specific
production of TCRγ rearrangements in fetal thymocytes that can be inhibited by E2A
activity (61).
Calibrating the significance of quantitative differences: the TCF/LEF family transcription
factors
The postnatal-specific defects in TCF-1 deficient mutants, discussed above, raise the
question of why fetal pro-T cell development appears to be able to use LEF-1 as a substitute
for TCF-1, while adult pro-T cell development cannot. Direct quantitative comparison
suggests a simple explanation. TCF-1 levels rise gently (about 3-5 fold) in adult pro-T cells
from the DN1 to the DN3 stage, as shown in Fig. 7A and Fig. 4A, and the levels for fetal
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thymocytes are completely within the range of variation between adult sample series, a
perfect example of a “class 1” pattern. However, LEF-1 regulation is modestly but
informatively different. It is upregulated sharply between the DN2 and DN3 stages in both
adult and fetal pro-T cells, but in all cases its levels in the fetal cells are higher, by 3-10 fold
(Fig. 7B). The difference is not as dramatic as for the Id factors (cf. Fig. 6), but it puts
LEF-1 into the same expression level range as TCF-1 in the fetal case while it is always the
minority factor in the adult case, at least based on RNA levels. The fact that this difference
is correlated with a biologically significant difference in impairment in fetal and adult
TCF-1 knockout animals (106-108) implies that the greater quantitative differences seen in
more definitive “class 3” cases may also have a functional impact.
Similarities in the DN1 and DN2 stages defined by Runx and Gfi1 family transcription
factors
Important roles in proliferation and differentiation of pro-T cells are served by Runx and
Gfi1 family transcription factors (rev. by (1)). While Runx1 and Runx3 have been studied
most in the context of CD4 gene regulation later in T-cell development, Runx1 is crucial for
the differentiation of pro-T cells (44;166-168). Gfi1 family factors are likely to act as key
regulators of population expansion and quiescence in pro-T cells from the stem-cell stages
onward (169-172). Two related genes from each of these families are expressed strongly in
the pro-T cell stages: Runx1 and Runx3 (Fig. 7C, D), and Gfi1 and Gfi1B (Fig. 7E, F).
Three of these four genes exemplify “class 2” comparisons. All four transcription factors are
expressed in both adult and fetal pro-T cells, and their mRNA levels are very similar in both
kinds of samples in the DN1 and DN2 stages. Runx1 levels gently rise from the DN1
through the DN3a stage, then fall steeply after β-selection in the adult samples (DN3b, DN4;
Fig. 7C). However, in the fetus, the high levels of Runx1 expression seen in DN2 and DN3
cells are also sustained through the DN4 stage. Runx3 is expressed in a slightly different
pattern, first at a high level in DN1 and DN2 cells and then, in the adult, showing a decline
that begins in the DN3 stage before β-selection (Fig. 7D, DN3a vs. DN2). In the fetus,
however, Runx3 is sustained at high levels all the way through the DN4 stage, already
diverging from the adult pattern by the DN3a stage (Fig. 7D). A very similar pattern to that
of Runx3 is shown by Gfi1B (Fig. 7F), which starts at a high level in DN1 and DN2 and
declines only minimally after that in the fetal pro-T cells. In adult samples, on the other
hand, Gfi1B expression starts at similar levels to those in fetal DN1 and DN2 cells, but then
drops precipitously beginning at the DN3 (DN3a) stage. In contrast to all these “class 2”
examples, Gfi1 represents a “class 1” gene, with only small and irreproducible changes
between the adult and fetal series (Fig. 7E).
The “class 2” expression pattern of Gfi1B, Runx1, Runx3, and genes to be discussed below
provide an initial clue that regulatory differences between fetal and adult early T cells are
concentrated at the stages of β-selection checkpoint arrest and β-selection itself, rather than
in the earlier specification stages.
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ETS family factors and the non-redundancy of PU.1 and SpiB
The Ets transcription factor family is particularly interesting because it includes many
factors with potentially redundant function (173) and overlapping expression patterns in pro-
T cells (115), yet there are specific genetic requirements for individual Ets-family factors in
T-cell development (174-180). The positive requirement for the Ets factor PU.1 is one of the
features that appears to shift between fetal and postnatal pro-T cells (75), even though
excess expression of this factor interferes with pro-T cell development in adult and fetal
cells alike (135-137). The family includes striking examples of “class 1”, “class 2”, and
“class 3” relationships between adult and fetal expression patterns.
Both Ets1 and Ets2 are expressed with a 5-10 fold upsurge between the DN2 and DN3
stages, followed by a relative plateau (Fig. 8A, B). Ets1 is expressed almost
indistinguishably between adult and fetal pro-T cell samples of corresponding stages, a
perfect example of a “class 1” gene (Fig. 8A). Ets2 is also expressed similarly, though at a
slightly higher level throughout in the fetal cells (Fig. 8B), reminiscent of the regulation of
LEF-1 (cf. Fig. 7B). At most stages, however, the difference between average fetal and adult
levels of Ets2 is less than three fold.
Another Ets-family transcription factor, MEF, was examined because of its importance for
NK cell maturation (181), but showed relatively constant expression and similar levels in
adult and fetal pro-T cells (data not shown).
PU.1 and SpiB are both expressed in adult pro-T cells, but in different patterns, with SpiB
maximal in the newly committed cells at the DN3 (DN3a) stage as PU.1 is being sharply
repressed (114;115;135;136). They have extremely similar DNA binding specificities but
differences in protein-interaction domains outside of the DNA binding domain (rev. by
(173)). There is some evidence that these factors can act redundantly (182), and at
artificially high levels both of them can interfere with T-cell development similarly
(135;136;183), but this redundancy is not seen in all contexts (136;184). In particular, it is
not known whether SpiB is structurally competent to fulfil the early positive role for PU.1
that is needed for pro-T cell development. If the factors could act redundantly in the pro-T
cell context, then one way that postnatal T-cell development could become less dependent
on PU.1 might be by expressing higher levels of SpiB during the DN1 and DN2 stages than
in fetal pro-T cells.
The results shown in Fig. 8C and D completely refute this prediction. The surprise is not
with PU.1, which shows a close match between its expression levels in fetal and adult pro-T
cells throughout the DN1 and DN2 stages, then declines sharply (Fig. 8C; cf. Fig. 4A).
There is some difference between adult and fetal patterns for PU.1, as it continues to drop
from the DN3a stage onward in the adult (>200 fold overall) but stabilizes expression at the
DN3a level in the fetus (Fig. 8C), a “class 2” like relationship. Nevertheless, the 30-fold
overall drop in PU.1 levels in the fetus from DN1 to DN3 are presumably sufficient to allow
T-lineage commitment. In contrast, the SpiB expression is unexpectedly different in fetal
and adult cells, in the opposite direction of that predicted. A striking example of a “class 3”
gene, SpiB is expressed at a much higher level in the fetal pro-T cells than in the adult pro-T
cells (at least tenfold higher; Fig. 8D). Because of the extensive alternative splicing of SpiB
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in pro-T cells (115), its expression was tested with two different sets of primers designed to
cross a different intron, and the results were the same (data not shown). While SpiB RNA
levels in the adult pro-T cells are always relatively low, the level of SpiB RNA expression in
the fetal DN3 cells appears to be high in relation to the highest levels of PU.1 or other Ets
factors at any stage of pro-T cell development. Thus, if SpiB levels have any relationship to
the change in PU.1 dependence between fetal and postnatal pro-T cell development, then it
must be by acting as an antagonist of PU.1 rather than as a redundant agonist.
The PU.1/SpiB relationship marks a specific alteration in pro-T cell developmental
regulation between fetal and adult. As noted above, Ikaros also appears to be more essential
for thymocyte development in fetal life than after birth. However, in contrast to PU.1 and
SpiB, expression patterns of the Ikaros family genes Ikaros, Aiolos, and Helios did not show
substantial differences in pattern or level between corresponding adult and fetal samples
beyond the scatter of the data (data not shown).
T-lineage signature genes: splitting the specification process
The OP9-DL1 system for inducing T-cell development in monolayer culture has been
extremely useful to identify genes that are turned on in lymphoid precursors very
specifically in response to Notch/Delta signaling (116;117;139): these define a
“specification group” of T-cell genes. Among these genes is TCF-1, which we have already
examined (Figs. 4A, 7A). Another of these genes is the essential T-lineage transcription
factor GATA-3, previously encountered in Fig. 4A. As shown in Fig. 9A, like TCF-1,
GATA-3 is also expressed with a very gentle increase from DN1 to DN3, and with little
difference between fetal and adult pro-T cells (disregarding a stray point in one fetal
sample). Thus GATA-3 falls into the “class 1” category as well. The constant regulatory
features between fetal and adult programs are not confined to these two genes induced at the
earliest stages of the T-cell specification process. We have seen that Ets1, which is
upregulated only at the DN3 stage, is also a “class 1” gene, and Fig. 9B shows that another
gene upregulated at the same time, encoding the POU domain factor Pou6f1 (Brn-5), is also
upregulated indistinguishably between adult and fetal pro-T cells. Thus there is a regulatory
core of the T-cell specification process induced by Notch which appears to be qualitatively
and quantitatively invariant between fetal and adult pro-T cell development.
Thus it is particularly surprising that two other major Notch-activated genes, CD3ε and
Deltex1, are not regulated similarly in adult and fetal pro-T cells, but instead provide
dramatic examples of “class 3” genes (Fig. 9C, D). In both adult and fetal pro-T cells,
expression of these genes rises to a peak in the DN3/DN3a stage, as expected for the known
importance of Notch signaling at this point (138) and in agreement with the expression of
known Notch target genes (T. Taghon, M. A. Yui, R. Pant, R. A. Diamond, and E. V. R.,
ms. submitted for publication). However, there is a substantial quantitative difference
between the magnitudes of CD3ε and Deltex1 expression in fetal and adult thymocytes, with
about tenfold higher mRNA levels in each case in the fetal cells. While CD3ε expression
follows the same relative pattern of expression in fetal and adult cells, the higher overall
levels shown in Fig. 9C could predict a more efficient assembly or a higher signaling
capability for TCRγδ or pre-TCR complexes in the fetal DN3 cells than in the adult. In the
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case of Deltex1, not only is the level altered but also the pattern of expression, with what
appears to be a persistence of Deltex1 expression after β-selection in the fetal case that
contrasts sharply with the adult case (Fig. 9D). The role of Deltex1 in T-lineage
differentiation is not clear, but as an indicator of Notch signaling (161) it implies that Notch
signals themselves may be sustained past the β-selection checkpoint in the fetus in a way
that they are not in the adult.
Summary of comparisons
These results have several implications. First, they indicate that there is an invariant core of
events in T-cell specification, involving relatively fixed benchmarks for expression of
GATA-3, TCF-1, HEB, E2A, and other genes, and that key transitions such as that from
DN2 to DN3 are accompanied by an almost-invariant set of regulatory changes, with
upregulation of genes like Ets1, Ets2, LEF-1, and Pou6f1. Second, however, other
regulatory molecules in the T-cell specification process are not used in quantitatively similar
ways even between adult and fetal T-cell development in the same species, and these include
both the critical TCR complex signaling component, CD3ε and a direct indicator of Notch
signaling, Deltex1. Third, the results indicate that in some ways the fetal DN1 and DN2
stages are more similar to those of the adult than the DN3 and DN4 stages. It is at the DN3
stage and at β-selection that the most consistent differences between fetal and adult appear.
Fourth, while part of the fetal-adult difference may reflect the greater presence of γδ cells in
the fetal DN4 subset, it is notable that several of the gene regulatory differences between
adult and fetal pro-T cells begin before β-selection, in the DN3/DN3a cells. Most of them
have the character of blurring the discontinuities that occur in the adult at β-selection:
especially, deferring the repression of genes like Runx3, Gfi1B, Deltex1, and even PU.1.
Fetal pro-T cell development appears to preserve more “pre-commitment” regulatory
character through commitment and into the DN4 stage than in the adult.
Conclusions
The developmental changes that occur in the pro-T cell stages include both a central
differentiative core, that defines these cells as T-lineage precursors, and variable features
that can be modulated in different stages of ontogeny or in different pathological situations.
Among the features that are known to differ, there is the variable extent of cytokine-driven
proliferation in the DN1 and DN2 stages, the ragged onset of T-cell differentiation gene
expression with respect to the specification process, the varying predisposition to give rise to
different αβ or γδ T cell progeny, and the variable extent of proliferation after pre-TCR or
TCRγδ-dependent selection. Here a comparison between patterns of regulatory gene
expression in the adult and fetal cases provides evidence to begin to categorize those
functions that are truly constant in the T-cell specification process and distinguish them from
those which may control these variations.
A strikingly constant regulatory ensemble appears to be provided by the expression patterns
of TCF-1 and GATA-3, which are induced early in response to Notch signaling and show a
gradual increase through the pro-T cell stages; by E2A and HEB, which are expressed at
high levels throughout pro-T cell development; by Ets1 and Pou6f1, which are crisply
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upregulated between the DN2 and DN3 stages; and by the declining level of PU.1, which is
repressed with increasing severity from the DN1 to the DN3 stage. Ikaros and Helios,
expressed throughout the pro-T cell stages, and Aiolos, induced predominantly at β-
selection, are also similar in level in fetal and adult pro-T cells (M. M. and E.-S. D., data not
shown)(T. Taghon, M. A. Yui, R. Pant, R. A. Diamond, and E. V. Rothenberg, ms.
submitted). Also similar are the absences of expression of C/EBPα and C/EBPβ
transcription factors throughout these stages and the initially low, rapidly extinguished
expression of GATA-2 in fetal and adult pro-T cells (M. M. and E.-S. D., data not shown).
The constant significance of the transition from the DN2 to the DN3 stage is also underlined
by the consistent upregulation of LEF-1 and Ets2 at this point, albeit to somewhat different
levels in fetus and adult.
The results present some surprises about the stages that are most divergent. In spite of the
differences in transit rate from DN1 to DN3 stages, the majority of regulatory genes we
examined were expressed at virtually indistinguishable levels between fetus and adult
through the DN1 and DN2 stages, often into the DN3a (preselection) stage. The differences
were most common and most pronounced in the stages immediately attending β-selection or
γδ-selection. This indicates that a constant regulatory core is likely to be critical for
successful T-lineage specification itself, i.e. the accurate funneling of cells into the T-lineage
program from what may be diverse progenitor-cell states. On the other hand, the regulatory
features of β-selection checkpoint enforcement may be profoundly variable between E14.5
fetus and adult. This was not anticipated and is rarely addressed in the literature. Part of the
difference may reflect the differentiation of first-wave γδ cells, unique to the fetus, which
would make the composition of the DN4 and DN3b populations more γδ-dominated than in
the adult. However, so many of the changes effectively perpetuate DN2/DN3a gene
expression patterns into the DN4 stage, it appears that the fetal thymocytes lack the entire
regulatory discontinuity that β-selection entails in the adult. Even the “class 1” genes, which
are expressed similarly between fetal and adult thymocytes, do not reveal any clear
discontinuity in fetal thymocytes at β-selection, because all the genes in this category are
expressed at fairly constant levels from the DN3a to DN4 transition in adult cells as well. It
is possible that β-selection, in its sense of conferring a distinctive regulatory profile on DP
thymocytes, may not be the same process in adult and fetus at all.
Finally, overall, the fetal pro-T cell specification process is shown to deploy a highly
distinctive balance of potent regulators that should make it work differently from the adult
process in several respects. One can only speculate at this point about the consequences of
these differences. The genes that are expressed differentially between fetus and adult include
factors implicated in proliferation, such as Runx1, Runx3, Gfi1B, LEF-1, Ets2, and the Id
factors. This set of genes may indeed underlie fetal-specific regulation of population
dynamics. It is important to emphasize also that these genes are likely to control other
functions besides proliferation. Runx factors control the timing of CD4 expression
(168;185;186). The abundance of Id1 and Id2 expression could contribute directly to the use
of fetal-type TCRγ and TCRδ segments in early gene rearrangements, facilitating the
predominance of cells with these receptors in the first wave of fetal thymocyte development
(61;187).The massively higher expression of Id1 and Id2 could possibly relax some
checkpoint controls (163), even while the massively higher expression of SpiB might tend to
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restrain some of that progression (136). At the same time, the augmented expression of
CD3ε in fetal pro-T cells could facilitate strong signals that might assist in the selection of
γδ cells in the first wave of T-cell development, according to an emerging strength-of-signal
model for γδ-T cell lineage choice (188-190). The functional impact of the strikingly
elevated Deltex1 expression is harder to guess, but it suggests at a minimum that Notch
signaling is even more powerful and sustained in the fetal thymus than in the adult. The
suggestion that Notch signaling continues through β-selection would mark a sharp
qualitative difference between fetal and adult thymocyte development, one that could dwarf
the differences seen in the pro-T cell stages.
The distinctive features of pro-T cell development in the fetal thymus provide concrete
evidence to explain why the behavior of fetal cells may fail to match their adult counterparts
experimentally. They also provide an invitation to explore the potential for regulatory
flexibility that is inherent in the T cell program. The results described here may begin to
indicate points of separation between pure differentiation functions and population
expansion regulators, and shed some light on the ways T-cell development reconciles the
need to maintain a robust and sophisticated differentiation program with contexts of highly
varying population dynamics.
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Figure 1.
Crucial regulatory inputs into the T-cell commitment process.
Genetic evidence shows that eight transcription factors or transcription factor families plus
the Notch/Delta signaling system have essential roles in the generation of committed pro-T
cells from hematopoietic stem cells (HSC). The figure summarizes data reviewed in (1).
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Figure 2.
Summary of T-cell development: stages, branchpoints, and checkpoints.
Prethymic (yellow background) and intrathymic (white, green backgrounds) stages of T-cell
development are diagrammed, in the context of the developmental options open to cells at
each stage. White circles depict multipotent progenitors, black circles depict T-lineage
committed stages, and the gray circle depicts the intermediate state of specified but
uncommitted DN2 pro-T cells. “Commitment early” is the loss of B-cell potential, described
in the text, and “commitment late” is the conclusion of T-lineage commitment with the loss
of NK, DC, and macrophage (Mac) potentials. “Specification” denotes the gradual and
asynchronous onset of T-lineage differentiation gene expression as described in the text.
“Commitment late” concludes the TCR-independent phase of T cell development. Although
cells from the DN3 stage onward can continue to give rise to different types of T cells, they
can no longer give rise non-T cells unless genetically perturbed. “β-selection” is the strong
proliferative and differentiative stimulus given only to those cells that successfully undergo
productive TCRβ rearrangement; this marks the end of the pro-T cell stages. TCRγδ cells in
general emerge when both γ and δ TCR chains are successfully rearranged before successful
TCRβ rearrangement.
Abbreviations: HSC/MPP: hematopoietic stem cell/multipotent progenitor; L/M Pre,
putative lympho-myeloid restricted progenitor (26); Eryth/megak, erythroid or
megakaryocytic. For all intrathymic stages, DN= CD4- CD8- (and surface TCR- here). DN1
= c-kit++ CD44+ CD25-; DN2 = c-kit++ CD44+ CD25+ HSA+; DN3 = c-kit- CD44- CD25+
HSA+; DN4 = c-kit- CD44-CD25- HSA+ intracellular TCRβ+. After DN stages, ISP =
immature single positive, CD4- CD8+ intracellular TCRβ+; DP = double positive, TCRlow
CD4+ CD8+ ; CD8 = mature TCRαβ+ CD4- CD8+; CD4 = mature TCRαβ+ CD4+ CD8-.
DN1, DN2, and DN4 are the main stages of proliferation in the thymus. Most TCR gene
rearrangement occurs in the DN3 and DP stages.
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Figure 3.
Developmental progression vs. population dynamics mechanisms: sources of potential
flexibility in the subset distributions of developing T-lineage cells.
Schematic depiction of the flexibility, in principle, that could enable the same number of
DN1 cells to give rise to more or less DN2 and later derivatives in a steady state thymus
without affecting the differentiation program as such. Evidence suggests that proliferation,
selection criteria, and timing of cell death may be based on separable mechanisms from
acquisition of T-cell characteristics (see text).
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Figure 4.
Expression patterns of T-lineage transcription factor and differentiation genes in pro-T cells:
disparate rates of developmental change.
(A) Q-PCR analysis of the expression of four critical T-lineage transcription factors and the
differentiation gene CD3ε in the DN1-3 stages and through β-selection. Expression levels of
these genes were determined in two independent series of sorted DN1-DN4 thymocytes,
normalized to β-actin and averaged, and are shown on a log scale. Results for all genes were
obtained from the same samples. See text for discussion. (B) and (C) Two models to explain
why the increase in “differentiation gene” expression from before specification to
commitment should be so much steeper than the increase in T-lineage transcription factor
gene expression. (B) Expression of the differentiation gene may depend on combinatorial
interactions between transcription factors, so that individual cis-regulatory site occupancies
must be multiplied to generate the output expression level. (C) Expression of the
differentiation gene may depend not on the known factors, but on an unknown transcription
factor that undergoes a steeper increase in its own expression from DN1 to DN3 stage. In
this version of the model the unknown transcription factor (X) is itself proposed to be
activated by an unspecified combination of other T-lineage regulators. A third possible type
of model, not shown, could include steeply downregulated factors like PU.1 as possible rate-
David-Fung et al. Page 34
Immunol Rev. Author manuscript; available in PMC 2014 September 08.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
limiting antagonists of differentiation gene expression. Unfortunately, the regulatory
sequences for CD3ε itself are still uncharacterized and cannot help to distinguish yet
between these types of models.
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Figure 5.
Asynchronous and noncoordinate onset of T-lineage gene expression during T-lineage
specification: alternative programs of gene activation?
This figure compares gene expression in definitively specified pro-T cells (DN2, DN3) with
gene expression in diverse populations of pre-specification thymocytes [all CD44+ CD25-,
mostly also HSA (CD24) low] that differ in T-lineage potential.
(A) The most primitive c-kit+ DN1 cells are found in the Sca-1+ Thy-1lo HSAlo population
(green arrows). Data are shown from a five-color flow cytometric analysis of wildtype DN
thymocytes (B6 depl = B6 depleted of CD8+, TCR+, and non-lymphoid cells). A parallel
analysis is shown of TCRβ-/- δ-/- mutant thymocytes which cannot progress beyond the DN3
stage, confirming that all the subsets shown are generated through TCR-independent
processes. HSA is strongly expressed by all CD25+ DN cells (DN2 and DN3), by DN4 cells,
and by any B-lineage precursors (39). The HSA-low/negative subsets can be subdivided by
Thy-1, Sca-1, NK1.1, c-kit, and other markers to provide sensitive discrimination of DN1
cells (“DN1a”, (18)) and other immature minority populations (39;115;120;124;192). Top
panels: c-kit+ DN1 cells are found in the Sca-1+ population of HSAlo cells, not the Sca-1-
HSAlo cells. Middle panels: HSAlo c-kit+ cells (“DN1a”, (18)) are predominantly Sca-1+
Thy-1lo, but as they acquire HSA (“DN1b”, (18)) they also become Thy-1hi.
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(B) Definition of thymocyte subsets for gene expression analysis. In both wildtype
thymocytes and mutants blocked in pre-TCR assembly, Sca-1hi and Sca-1lo subsets of
HSAlo thymocytes are further subdivided by Thy-1 and CD4 staining. TCRβ-/- δ-/- results
shown in upper panel are representative of Rag-2-/- and SCID subpopulations as well (M. A.
Y., unpublished data). In all these mutants, populations 1 and 2, Sca-1lo Thy-1+ and Thy-1-
cells, are shown elsewhere to express NK1.1 and CD122 almost uniformly and represent NK
lineage cells (115;120;124). Sca-1+ HSAlo cells were separated into CD4- Thy-1lo
(population 3) and CD4- Thy-1+ (population 5) subsets. CD4+ cells were sorted separately
(population 4) (118); but in mutant thymocytes that cannot undergo β-selection, this
population does not contain any T-cell precursors (122). Numbering of subsets in this panel
corresponds to numbers in panel C and lane numbers in panels D & E.
(C) TCR-independent differentiation potential in TCRβ-/-δ-/- HSA-low DN cells is confined
to cells in HSA-low DN population 3. Mutant thymocytes unable to go through β-selection
were used to eliminate the possibility of more mature cell contaminants in any HSA-low DN
fractions. Thy-1, CD44, and HSA staining profiles are shown for populations 1+2,
population 3, and population 5, isolated as in panel B, both initially and after reaggregation
into thymic epithelial lobes and culture for 8-14 days in fetal thymus organ culture. Note
that only descendents of population 3 generated HSA+ Thy-1+ CD44- DN3 cells.
Descendents of populations 1+2 remained unchanged and also retained predominant NK1.1+
phenotype after fetal thymic organ culture (M. A. Y., unpublished data). Descendents of
population 5 failed to proliferate or generate DN3 cells in spite of their high Thy-1+
phenotype and expression of certain other T-lineage genes (panels E & E).
(D) and (E) Expression of T-lineage and non-T-lineage genes in subsets of pro-T cells and
other HSA-low DN thymocytes. Thymocytes from two different mutant mouse strains that
are arrested at the β-selection checkpoint were used as starting material to exclude any
possible contamination with mature TCR+ cells. Populations 1-5 were sorted as indicated
(cf. panel B) and compared with DN2 (CD25+ CD44+ HSA+, pop. 6) and DN3 (CD25+
CD44- HSA+, pop. 7) cells from the same thymus. Semiquantititative RT-PCR analyses
were performed as previously described (115;119;124;192) using primers for T-lineage
genes and “lineage inappropriate” genes (indicated by asterisks: genes expressed
preferentially in B-lineage, monocytic, and dendritic cells). The results shown are
representative of over six independent experiments with Rag-2-/-, TCRβ-/- δ-/-, and SCID
thymocytes (H. W., R. A. D., and E. V. R., unpublished data). Note that all the T-lineage
genes and none of the “inappropriate” genes are expressed in both DN2 and DN3 stages,
whereas the gene expression patterns in populations 3, 4, and 5 reveal substantial diversity
and suggest some early cross-lineage gene activation.
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Figure 6.
Comparison of bHLH transcription factor and antagonist gene expression in fetal and adult
DN thymocytes, pro-T stages through β-selection: fetal-specific increase in Id1 and Id2. Q-
PCR analyses of expression of the bHLH factors HEB (A) and E2A (B) and the antagonists
Id1 (D), Id2 (E), and Id3 (C) are shown for two independent series each of E14.5 fetal and
adult DN thymocyte subsets. Primers used for the realtime PCR analysis are listed in Table
1. Adult (navy and magenta) and fetal (yellow and cyan) data are presented as individual
series without averaging, to distinguish systematic variation between fetal and adult series
from variation between independent samples of the same type. The adult samples shown
here and in Figs. 7-9 are different sets from those used to generate Fig. 4. However, all the
samples used in Figs. 6-9 are the same and the results shown are directly comparable. Adult
and fetal thymocytes were both prepared by first depleting CD8+, CD3+, TCRγδ+, and
Ter-119+ cells, and then performing two sorts on the FACSAria. DN1, DN2, DN3a, and
DN3b cells were sorted based on c-kit, CD27, CD44, and CD25 expression from one
aliquot, while total DN3 (DN3-t) and DN4 cells were sorted based on c-kit, CD44, CD25,
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and HSA expression from another aliquot or another cell preparation. In the graphs, DN3-t
samples are ordered between the DN2 and DN3a samples to reproduce the DN1-DN2-DN3
(total) succession shown in Fig. 4, to permit the most direct comparison between DN3a and
DN3b, and to juxtapose DN3b samples with the DN4 samples that represent their immediate
descendents. Note that for genes that are strongly upregulated at β-selection like Id3 (C), the
inclusion of DN3b-type cells in the DN3-t sample can make the trend lines appear jagged.
As we report elsewhere in detail (T. Taghon et al., submitted), the effects of β-selection in
adult thymocytes are seen most clearly in the comparison between DN3a (preselection) and
DN3b (newly selected) cells.
In these panels, note that the variability between series in panels (A) and (B) (especially
adult samples after β-selection, magenta and navy) fully encompasses the differences
between adult and fetal samples. For calibration of these differences, compare the similar
patterns and levels of expression of HEB (A) with those from independent samples in Fig.
4A. In contrast, the fetal expression patterns (yellow and cyan) lie distinctly outside the
adult patterns (magenta and navy) in panels (D) and (E).
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Figure 7.
Comparison between adult and fetal pro-T cell expression of TCF/LEF, Runx, and Gfi1
family transcription factors: differences in magnitude and regulation post β-selection. (A)
TCF-1 (Tcf7) expression. (B) LEF-1 expression. (C) Runx1 expression. (D) Runx3
expression. (E) Gfi1 expression. (F) Gfi1B expression. See legend to Fig. 6 for explanation
of samples. Primers used in Q-PCR analyses are listed in Table 1. Compare the similar
levels and patterns of TCF-1 expression (A) with those in independent samples in Fig. 4A.
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Figure 8.
Comparison between adult and fetal pro-T cell expression of Ets family transcription
factors: fetal-specific upregulation of SpiB.
(A) Ets1 expression. (B) Ets2 expression. (C) PU.1 expression. (D) SpiB expression. See
legend to Fig. 6 for explanation of samples. Compare the similar levels and patterns of PU.1
expression in the adult samples in (C) with those shown in independent samples in Fig. 4A.
David-Fung et al. Page 41
Immunol Rev. Author manuscript; available in PMC 2014 September 08.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 9.
Comparison between adult and fetal pro-T cell expression of distinctly regulated
components of the T-cell specification gene set.
(A) GATA-3 expression. (B) Pou6f1 expression. (C) CD3ε expression. (D) Deltex1
expression. See legend to Fig. 6 for explanation of samples. For adult samples, compare the
similarity between the GATA-3 and CD3ε levels and patterns of expression in (A) and (C)
with those shown in independent samples in Fig. 4A. Although both are tightly associated
with the T-cell specification mechanism, both CD3ε and Deltex1 are expressed at
remarkably different levels in fetal and adult thymocytes from the earliest DN1 stage
throughout the pro-T cell stages.
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TABLE 1
PRIMERS FOR Q-PCR ANALYSIS
GENE NAME Forward Primer Reverse Primer
1 Aiolos CCGAGATGGGAAGTGAGAGA CGCTTCTCACCGATGAATTT
2 β-actin ACACCCGCCACCAGTTC TACAGCCCGGGGAGCAT
3 CD3ε CGTCCGCCATCTTGGTAGAG ATTCAATGTTCTCGGCATCGT
4 C/ebpα CGGTCATTGTCACTGGTCAACT GGACAAGAACAGCAACGAGTACC
5 C/ebpβ GTTTCGGGACTTGATGCAATC CGCAGGAACATCTTTAAGGTGAT
6 C/ebpδ TCCACGACTCCTGCCATGTA TGAAGAGGTCGGCGAAGAGTT
7 C/ebpγ GCGCAGGTACATGTGAAGATT CTGCGACAGCTTGCTCATT
8 Deltex1 GAGGATGTGGTTCGGAGGTA CCCTCATAGCCAGATGCTGT
9 E2A CAGATGGTGGCCTGGATACT CATCCCTGCTGTAGCTGTCA
10 Ets1 AAAAGTGGATCTCGAGCTTTTCC CTTTCAAGGCTTGGGACATCA
11 Ets2 GCAAGGCAAACCAGTTATTCCT ACTTGTCAGAGAGTAGCTCCAGAAGAA
12 Gapdh ACTCCACTCACGGCAAATTCA GCCTCACCCCATTTGATGTT
13 Gata2 ACCACAAGATGAATGGACAGAA GTCGTCTGACAATTTGCACAAC
14 Gata3 GAGGTGGTTGTCTGC TTTCACAGCACTAGAGACCCTGTTA
15 Gfi1 CGAGTTCGAGGACTTTTGGA CATGCATAGGGCTTGAAAGG
16 Gfi1b CCTTTGCCTGTGATGTCTGT ATGAACGCTTGAAGGCTTTG
17 HEB GAGAAGAAGACCGCTCCATGAT TGGCTTGGGAGATGGGTAAC
18 Helios CACCTCAGGACCCATTCTGT TGACAGCGTTCCTTGTGTTC
19 Id1 GGCGAGATCAGTGCCTTG AAGGGCTGGAGTCCATCTG
20 Id2 GTCCTTGCAGGCATCTGAAT CTCCTGGTGAAATGGCTGAT
21 Id3 AGAGGAGCTTTTGCCACTGA TGGAGAGAGGGTCCCAGAGT
22 Ikaros TCCCAAGTTTCAGGAAAGGA TCTGCTGTGCTCCAGAGGTA
23 IL2-UP ACCTTGGGAGCTGAAATCCT TTTTGAGGGATCGCTAATGG
24 Lef1 ACCTACAGCGACGAGCACTT GGGTAGAAGGTGGGGATTTC
25 MEF CAGGCTCACCAAAACTGTGA TTGGTCAGCACCGTAGTCAG
26 Pou6f1 CTGCAACTCCCATCCCAATC CGCAAACTCCCGGATCTCTTCT
27 PU.1 CCCGGATGTGCTTCCCTTAT TCCAAGCCATCAGCTTCTCC
28 Rag1 GTTAACAACCAAGCTGCAGACATT TCATCGGGTGCAGAACTGAAG
29 Runx-1 CTCGGCAGAACTGAGAAATG GGTGATGGTCAGAGTGA
30 Runx-3 GGTTCAACGACCTTCGATTC GGTCCATCCACAGTGACCTT
31 SpiB CTTGCTCTGGAGGCTGCAC CCCCCATCTGAATCTGGGTA
32 Tbet AGGTGTCTGGGAAGCTGAGA ATTCGCCGTCCTTGCTTAGT
33 Tcf7 CAAGGCAGAGAAGGAGGCTAAG GGCAGCGCTCTCCTTGAG
Primers were used in an ABI 7700 Sequence Detector for the Q-PCR analyses shown in Figs. 4, 6-9 and additional data not shown. All detect
cDNA except IL2-UP (191), which was used to monitor cDNA samples for genomic DNA contamination.
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